MCK logo McKesson Corporation +
McKesson Corporation
+

McKesson Corporation Overview

Company: McKesson Corporation
CEO: Brian S. Tyler
Founded: 1833
Symbol: MCK
Exchange: NYSE
Industry: Medical - Distribution
Sector: Healthcare
About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Continue reading...

McKesson Corporation (MCK)

  • Stock Price
  • Volume
742.44 +550.61 +287.03%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

McKesson Corporation annual revenue was $403.43 B in 2026.

Net Income

McKesson Corporation annual net income was $4.76 B in 2026.

Employees

McKesson Corporation annual employee count was 43,000 in 2026.

Revenue by Segment

McKesson Corporation’s revenue by segment: Medical-Surgical Solutions Segment: $11.51 B, North American Pharmaceutical Segment: $336.65 B, Oncology And Multispecialty Segment: $48.42 B, Prescription Technology Solutions Segment: $5.81 B and Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment: $1.04 B in 2026.

Revenue by Region

McKesson Corporation’s revenue by region: International Segment: $38.34 B and UNITED STATES: $192.71 B in 2020.

Executive Salary

Brian S. Tyler Chief Executive Officer, at McKesson Corporation, mak...

Revenue per Employee

McKesson Corporation revenue per employee was $9.38 M in 2026.

Profit per Employee

McKesson Corporation profit per employee was $110.74 K in 2026.

Income Statement

Operating Income

McKesson Corporation annual operating income was $6.21 B in 2026.

Research & Development

McKesson Corporation annual research & development expense was - in 2026.

Tax Rate (%)

McKesson Corporation annual Tax Rate was 18.00% in 2026.

Assets & Liabilities | Cash Flow

Total Assets

McKesson Corporation annual total assets was $82.32 B in 2026.

Total Liabilities

McKesson Corporation annual total liabilities was $75.41 B in 2026.

Capital Expenditure

McKesson Corporation annual capital expenditures was - in 2026.

Ratios

Return on Equity (ROE)

McKesson Corporation annual return on equity(ROE) was 0.00% in 2026.

Return on Assets (ROA)

McKesson Corporation annual return on assets(ROA) was 0.00% in 2026.

Debt to Equity

McKesson Corporation annual debt to equity was -396.59% in 2026.

Profitability

Gross Profit Margin (%)

McKesson Corporation annual gross profit margin was 3.61% in 2026.

Operating Income Margin (%)

McKesson Corporation annual operating income margin was 1.54% in 2026.

Net Income Margin (%)

McKesson Corporation annual net income margin was 1.18% in 2026.

Earning Per Share

McKesson Corporation annual earning per share was $38.53 in 2026.

EBITDA

McKesson Corporation annual EBITDA was $6.21 B in 2026.

Free Cash Flow (FCF)

McKesson Corporation annual free cash flow(FCF) was $6.16 B in 2026.

Valuation

Enterprise value

McKesson Corporation annual enterprise value was - in 2026.

Enterprise value to Revenue

McKesson Corporation annual enterprise value to revenue was 0.00 in 2026.

Enterprise value to EBITDA

McKesson Corporation annual enterprise value to EBITDA was 0.00 in 2026.

Competitors’ Revenue

Frequently Asked Questions

When was McKesson Corporation founded?

McKesson Corporation was founded on 1833, which makes the company 193 years old.

Sign up for free to view

Who is the CEO of McKesson Corporation?

Brian S. Tyler is the CEO of McKesson Corporation.

What industry and sector is McKesson Corporation in?

McKesson Corporation operates in the Medical - Distribution industry and the Healthcare sector.

What are McKesson Corporation's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000927653
  • SIC (Standard Industrial Classification): 5122
  • ISIN (International Securities Identification Number): US58155Q1031

Sign up for free to view

How many employees does McKesson Corporation have?

McKesson Corporation has 43,000 employees.

What is the revenue of McKesson Corporation?

In fiscal year 2026, McKesson Corporation generated a revenue of $403.43 Billion.

What is the net income of McKesson Corporation?

In fiscal year 2026, McKesson Corporation reported a net income of $4.76 Billion.

What is McKesson Corporation's biggest product segment?

North American Pharmaceutical Segment is McKesson Corporation's biggest product segment, representing 83.45% of its total revenue.

When was McKesson Corporation listed on the stock exchange?

McKesson Corporation went public on Nov 10, 1994, through its Initial Public Offering (IPO), and it has been 31 years since then.

Sign up for free to view

What is the ticker symbol of McKesson Corporation, and where is it listed?

McKesson Corporation's ticker symbol is MCK, and the company is listed on the NYSE stock market exchange.

What is McKesson Corporation's current stock price?

McKesson Corporation's current stock price is $742.31 as of May 30, 2026.

What is McKesson Corporation's market capitalization?

As of , McKesson Corporation's market cap is .

What is McKesson Corporation's ranking in the world?

Ranked #22among 2,804 companies based on market cap.

Who are the top competitors of McKesson Corporation?

Competitors of McKesson Corporation include Cardinal Health and Cencora, and more.

Related company

Submit feedback to Bullfincher